- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Interleukin 1 (IL1) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Interleukin 1 (IL1) market. Detailed analysis of key players, along with key growth strategies adopted by Interleukin 1 (IL1) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
R Pharm
Swedish Orphan Biovitrum AB
Immune Response BioPharma Inc
Omnitura Therapeutics Inc
Optimum Therapeutics LLC
Opsona Therapeutics Ltd
Exicure Inc
Cell Medica Ltd
Orphit SAS
Regeneron Pharmaceuticals Inc
Apexigen Inc
XBiotech Inc
AbbVie Inc
Novartis AG
Anacor Pharmaceuticals Inc
Peptinov SAS
TWi Biotechnology Inc
By Type:
APX-002
Canakinumab
Diacerein CR
IR-1000
Others
By End-User:
Esophageal Cancer
Fallopian Tube Cancer
Bladder Cancer
Bechcer Disease
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Interleukin 1 (IL1) Market
-
1.3 Market Segment by Type
-
1.3.1 USA Interleukin 1 (IL1) Market Size and Growth Rate of APX-002 from 2016 to 2027
-
1.3.2 USA Interleukin 1 (IL1) Market Size and Growth Rate of Canakinumab from 2016 to 2027
-
1.3.3 USA Interleukin 1 (IL1) Market Size and Growth Rate of Diacerein CR from 2016 to 2027
-
1.3.4 USA Interleukin 1 (IL1) Market Size and Growth Rate of IR-1000 from 2016 to 2027
-
1.3.5 USA Interleukin 1 (IL1) Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Interleukin 1 (IL1) Market Size and Growth Rate of Esophageal Cancer from 2016 to 2027
-
1.4.2 USA Interleukin 1 (IL1) Market Size and Growth Rate of Fallopian Tube Cancer from 2016 to 2027
-
1.4.3 USA Interleukin 1 (IL1) Market Size and Growth Rate of Bladder Cancer from 2016 to 2027
-
1.4.4 USA Interleukin 1 (IL1) Market Size and Growth Rate of Bechcer Disease from 2016 to 2027
-
1.4.5 USA Interleukin 1 (IL1) Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Interleukin 1 (IL1) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Interleukin 1 (IL1) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Interleukin 1 (IL1) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Interleukin 1 (IL1) Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Interleukin 1 (IL1) Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Interleukin 1 (IL1) by Major Types
-
3.4.1 Market Size and Growth Rate of APX-002
-
3.4.2 Market Size and Growth Rate of Canakinumab
-
3.4.3 Market Size and Growth Rate of Diacerein CR
-
3.4.4 Market Size and Growth Rate of IR-1000
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Interleukin 1 (IL1) Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Interleukin 1 (IL1) by Major End-Users
-
4.4.1 Market Size and Growth Rate of Interleukin 1 (IL1) in Esophageal Cancer
-
4.4.2 Market Size and Growth Rate of Interleukin 1 (IL1) in Fallopian Tube Cancer
-
4.4.3 Market Size and Growth Rate of Interleukin 1 (IL1) in Bladder Cancer
-
4.4.4 Market Size and Growth Rate of Interleukin 1 (IL1) in Bechcer Disease
-
4.4.5 Market Size and Growth Rate of Interleukin 1 (IL1) in Others
5 Market Analysis by Regions
-
5.1 USA Interleukin 1 (IL1) Production Analysis by Regions
-
5.2 USA Interleukin 1 (IL1) Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Interleukin 1 (IL1) Landscape Analysis
-
6.1 West USA Interleukin 1 (IL1) Landscape Analysis by Major Types
-
6.2 West USA Interleukin 1 (IL1) Landscape Analysis by Major End-Users
7 South USA Interleukin 1 (IL1) Landscape Analysis
-
7.1 South USA Interleukin 1 (IL1) Landscape Analysis by Major Types
-
7.2 South USA Interleukin 1 (IL1) Landscape Analysis by Major End-Users
8 Middle West USA Interleukin 1 (IL1) Landscape Analysis
-
8.1 Middle West USA Interleukin 1 (IL1) Landscape Analysis by Major Types
-
8.2 Middle West USA Interleukin 1 (IL1) Landscape Analysis by Major End-Users
9 Northeast USA Interleukin 1 (IL1) Landscape Analysis
-
9.1 Northeast USA Interleukin 1 (IL1) Landscape Analysis by Major Types
-
9.2 Northeast USA Interleukin 1 (IL1) Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 R Pharm
-
10.1.1 R Pharm Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Swedish Orphan Biovitrum AB
-
10.2.1 Swedish Orphan Biovitrum AB Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Immune Response BioPharma Inc
-
10.3.1 Immune Response BioPharma Inc Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Omnitura Therapeutics Inc
-
10.4.1 Omnitura Therapeutics Inc Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Optimum Therapeutics LLC
-
10.5.1 Optimum Therapeutics LLC Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Opsona Therapeutics Ltd
-
10.6.1 Opsona Therapeutics Ltd Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Exicure Inc
-
10.7.1 Exicure Inc Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Cell Medica Ltd
-
10.8.1 Cell Medica Ltd Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Orphit SAS
-
10.9.1 Orphit SAS Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Regeneron Pharmaceuticals Inc
-
10.10.1 Regeneron Pharmaceuticals Inc Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Apexigen Inc
-
10.11.1 Apexigen Inc Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 XBiotech Inc
-
10.12.1 XBiotech Inc Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 AbbVie Inc
-
10.13.1 AbbVie Inc Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Novartis AG
-
10.14.1 Novartis AG Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Anacor Pharmaceuticals Inc
-
10.15.1 Anacor Pharmaceuticals Inc Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Peptinov SAS
-
10.16.1 Peptinov SAS Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 TWi Biotechnology Inc
-
10.17.1 TWi Biotechnology Inc Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of APX-002 from 2016 to 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of Canakinumab from 2016 to 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of Diacerein CR from 2016 to 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of IR-1000 from 2016 to 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of Esophageal Cancer from 2016 to 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of Fallopian Tube Cancer from 2016 to 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of Bladder Cancer from 2016 to 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of Bechcer Disease from 2016 to 2027
-
Figure USA Interleukin 1 (IL1) Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Interleukin 1 (IL1) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Interleukin 1 (IL1) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Interleukin 1 (IL1) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Interleukin 1 (IL1) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Interleukin 1 (IL1) Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Interleukin 1 (IL1)
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Interleukin 1 (IL1) by Different Types from 2016 to 2027
-
Table Consumption Share of Interleukin 1 (IL1) by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of APX-002
-
Figure Market Size and Growth Rate of Canakinumab
-
Figure Market Size and Growth Rate of Diacerein CR
-
Figure Market Size and Growth Rate of IR-1000
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Interleukin 1 (IL1) by Different End-Users from 2016 to 2027
-
Table Consumption Share of Interleukin 1 (IL1) by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Esophageal Cancer
-
Figure Market Size and Growth Rate of Fallopian Tube Cancer
-
Figure Market Size and Growth Rate of Bladder Cancer
-
Figure Market Size and Growth Rate of Bechcer Disease
-
Figure Market Size and Growth Rate of Others
-
Table USA Interleukin 1 (IL1) Production by Regions
-
Table USA Interleukin 1 (IL1) Production Share by Regions
-
Figure USA Interleukin 1 (IL1) Production Share by Regions in 2016
-
Figure USA Interleukin 1 (IL1) Production Share by Regions in 2021
-
Figure USA Interleukin 1 (IL1) Production Share by Regions in 2027
-
Table USA Interleukin 1 (IL1) Consumption by Regions
-
Table USA Interleukin 1 (IL1) Consumption Share by Regions
-
Figure USA Interleukin 1 (IL1) Consumption Share by Regions in 2016
-
Figure USA Interleukin 1 (IL1) Consumption Share by Regions in 2021
-
Figure USA Interleukin 1 (IL1) Consumption Share by Regions in 2027
-
Table West USA Interleukin 1 (IL1) Consumption by Types from 2016 to 2027
-
Table West USA Interleukin 1 (IL1) Consumption Share by Types from 2016 to 2027
-
Figure West USA Interleukin 1 (IL1) Consumption Share by Types in 2016
-
Figure West USA Interleukin 1 (IL1) Consumption Share by Types in 2021
-
Figure West USA Interleukin 1 (IL1) Consumption Share by Types in 2027
-
Table West USA Interleukin 1 (IL1) Consumption by End-Users from 2016 to 2027
-
Table West USA Interleukin 1 (IL1) Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Interleukin 1 (IL1) Consumption Share by End-Users in 2016
-
Figure West USA Interleukin 1 (IL1) Consumption Share by End-Users in 2021
-
Figure West USA Interleukin 1 (IL1) Consumption Share by End-Users in 2027
-
Table South USA Interleukin 1 (IL1) Consumption by Types from 2016 to 2027
-
Table South USA Interleukin 1 (IL1) Consumption Share by Types from 2016 to 2027
-
Figure South USA Interleukin 1 (IL1) Consumption Share by Types in 2016
-
Figure South USA Interleukin 1 (IL1) Consumption Share by Types in 2021
-
Figure South USA Interleukin 1 (IL1) Consumption Share by Types in 2027
-
Table South USA Interleukin 1 (IL1) Consumption by End-Users from 2016 to 2027
-
Table South USA Interleukin 1 (IL1) Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Interleukin 1 (IL1) Consumption Share by End-Users in 2016
-
Figure South USA Interleukin 1 (IL1) Consumption Share by End-Users in 2021
-
Figure South USA Interleukin 1 (IL1) Consumption Share by End-Users in 2027
-
Table Middle West USA Interleukin 1 (IL1) Consumption by Types from 2016 to 2027
-
Table Middle West USA Interleukin 1 (IL1) Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Interleukin 1 (IL1) Consumption Share by Types in 2016
-
Figure Middle West USA Interleukin 1 (IL1) Consumption Share by Types in 2021
-
Figure Middle West USA Interleukin 1 (IL1) Consumption Share by Types in 2027
-
Table Middle West USA Interleukin 1 (IL1) Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Interleukin 1 (IL1) Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Interleukin 1 (IL1) Consumption Share by End-Users in 2016
-
Figure Middle West USA Interleukin 1 (IL1) Consumption Share by End-Users in 2021
-
Figure Middle West USA Interleukin 1 (IL1) Consumption Share by End-Users in 2027
-
Table Northeast USA Interleukin 1 (IL1) Consumption by Types from 2016 to 2027
-
Table Northeast USA Interleukin 1 (IL1) Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Interleukin 1 (IL1) Consumption Share by Types in 2016
-
Figure Northeast USA Interleukin 1 (IL1) Consumption Share by Types in 2021
-
Figure Northeast USA Interleukin 1 (IL1) Consumption Share by Types in 2027
-
Table Northeast USA Interleukin 1 (IL1) Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Interleukin 1 (IL1) Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Interleukin 1 (IL1) Consumption Share by End-Users in 2016
-
Figure Northeast USA Interleukin 1 (IL1) Consumption Share by End-Users in 2021
-
Figure Northeast USA Interleukin 1 (IL1) Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of R Pharm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of R Pharm
-
Figure Sales and Growth Rate Analysis of R Pharm
-
Figure Revenue and Market Share Analysis of R Pharm
-
Table Product and Service Introduction of R Pharm
-
Table Company Profile and Development Status of Swedish Orphan Biovitrum AB
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Swedish Orphan Biovitrum AB
-
Figure Sales and Growth Rate Analysis of Swedish Orphan Biovitrum AB
-
Figure Revenue and Market Share Analysis of Swedish Orphan Biovitrum AB
-
Table Product and Service Introduction of Swedish Orphan Biovitrum AB
-
Table Company Profile and Development Status of Immune Response BioPharma Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immune Response BioPharma Inc
-
Figure Sales and Growth Rate Analysis of Immune Response BioPharma Inc
-
Figure Revenue and Market Share Analysis of Immune Response BioPharma Inc
-
Table Product and Service Introduction of Immune Response BioPharma Inc
-
Table Company Profile and Development Status of Omnitura Therapeutics Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omnitura Therapeutics Inc
-
Figure Sales and Growth Rate Analysis of Omnitura Therapeutics Inc
-
Figure Revenue and Market Share Analysis of Omnitura Therapeutics Inc
-
Table Product and Service Introduction of Omnitura Therapeutics Inc
-
Table Company Profile and Development Status of Optimum Therapeutics LLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Optimum Therapeutics LLC
-
Figure Sales and Growth Rate Analysis of Optimum Therapeutics LLC
-
Figure Revenue and Market Share Analysis of Optimum Therapeutics LLC
-
Table Product and Service Introduction of Optimum Therapeutics LLC
-
Table Company Profile and Development Status of Opsona Therapeutics Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Opsona Therapeutics Ltd
-
Figure Sales and Growth Rate Analysis of Opsona Therapeutics Ltd
-
Figure Revenue and Market Share Analysis of Opsona Therapeutics Ltd
-
Table Product and Service Introduction of Opsona Therapeutics Ltd
-
Table Company Profile and Development Status of Exicure Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exicure Inc
-
Figure Sales and Growth Rate Analysis of Exicure Inc
-
Figure Revenue and Market Share Analysis of Exicure Inc
-
Table Product and Service Introduction of Exicure Inc
-
Table Company Profile and Development Status of Cell Medica Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Medica Ltd
-
Figure Sales and Growth Rate Analysis of Cell Medica Ltd
-
Figure Revenue and Market Share Analysis of Cell Medica Ltd
-
Table Product and Service Introduction of Cell Medica Ltd
-
Table Company Profile and Development Status of Orphit SAS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orphit SAS
-
Figure Sales and Growth Rate Analysis of Orphit SAS
-
Figure Revenue and Market Share Analysis of Orphit SAS
-
Table Product and Service Introduction of Orphit SAS
-
Table Company Profile and Development Status of Regeneron Pharmaceuticals Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceuticals Inc
-
Figure Sales and Growth Rate Analysis of Regeneron Pharmaceuticals Inc
-
Figure Revenue and Market Share Analysis of Regeneron Pharmaceuticals Inc
-
Table Product and Service Introduction of Regeneron Pharmaceuticals Inc
-
Table Company Profile and Development Status of Apexigen Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apexigen Inc
-
Figure Sales and Growth Rate Analysis of Apexigen Inc
-
Figure Revenue and Market Share Analysis of Apexigen Inc
-
Table Product and Service Introduction of Apexigen Inc
-
Table Company Profile and Development Status of XBiotech Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of XBiotech Inc
-
Figure Sales and Growth Rate Analysis of XBiotech Inc
-
Figure Revenue and Market Share Analysis of XBiotech Inc
-
Table Product and Service Introduction of XBiotech Inc
-
Table Company Profile and Development Status of AbbVie Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc
-
Figure Sales and Growth Rate Analysis of AbbVie Inc
-
Figure Revenue and Market Share Analysis of AbbVie Inc
-
Table Product and Service Introduction of AbbVie Inc
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Anacor Pharmaceuticals Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anacor Pharmaceuticals Inc
-
Figure Sales and Growth Rate Analysis of Anacor Pharmaceuticals Inc
-
Figure Revenue and Market Share Analysis of Anacor Pharmaceuticals Inc
-
Table Product and Service Introduction of Anacor Pharmaceuticals Inc
-
Table Company Profile and Development Status of Peptinov SAS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Peptinov SAS
-
Figure Sales and Growth Rate Analysis of Peptinov SAS
-
Figure Revenue and Market Share Analysis of Peptinov SAS
-
Table Product and Service Introduction of Peptinov SAS
-
Table Company Profile and Development Status of TWi Biotechnology Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of TWi Biotechnology Inc
-
Figure Sales and Growth Rate Analysis of TWi Biotechnology Inc
-
Figure Revenue and Market Share Analysis of TWi Biotechnology Inc
-
Table Product and Service Introduction of TWi Biotechnology Inc
-

Chinese